We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients

This study is currently recruiting participants.
Verified October 2017 by Actinium Pharmaceuticals
Sponsor:
ClinicalTrials.gov Identifier:
NCT02575963
First Posted: October 15, 2015
Last Update Posted: October 4, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Actinium Pharmaceuticals
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2019
  Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)